No problem buddy!
Rather than try and guess and come up with a figure that may be misleading, I'll point you to this great recent presentation by Dr James Campbell in which he presented the facts around other recent preclinical deals. He goes into this at around the 12:30 mark and mentions specifically that for anti cancer drugs, 60% are licensed before the trials even starting.....interesting
Ann: Full size deoxymab PAT-DX3 crosses the blood brain barrier, page-48
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.34M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 2053666 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 3325244 | 5 |
View Market Depth
| Last trade - 16.12pm 19/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable